Patient satisfaction with testosterone replacement therapies: the reasons behind the choices
Open accessAbstract
Introduction: Testosterone replacement therapy (TRT) for male hypogonadism is rapidly gaining popularity and acceptance. Options include gels, injections, and implantable subcutaneous pellets. Aims: The aim of this study was to determine rates of patient satisfaction and reasons for patient preferences in hypogonadal men on TRT. Methods: An anonymous, prospective survey was distributed to men presenting for TRT at an academic urology clinic. The survey was organized into multiple domains including patient satisfaction and treatment motivation. Main Outcome Measures: Patient satisfaction responses obtained via anonymous survey. Results: Average patient age was 49 ± 0.7 years (n = 382). Injectable testosterone was chosen by 53%, gel-based regimens by 31%, and pellets by 17%. Overall, 70% of patients were satisfied with their TRT and 14% reported dissatisfaction. Satisfaction rates were similar between gels (68%), injections (73%), and implantable pellets (70%). Doctor recommendation was the sole significant reason for patients preferring gel-based TRT (66% vs. 37% injection users vs. 31% pellet users). Injectable TRT was favored because of lower cost (35% vs. 21% gel users vs. 19% pellet users). Pellets were favored for ease of use (64% vs. 44% injection users vs. 43% gel users) and convenience (58% vs. 26% injection users vs. 19% gel users). Pellets had increased rates of satisfaction within the first 12 months. Improvements in concentration and mood occurred at higher percentages in satisfied patients. Conclusions: Patients are satisfied with TRT. Lower costs are important to patients on injections. Convenience and ease of use are central in choosing pellet therapy. Men on TRT should be questioned about mood and concentration because these factors exhibited the greatest improvements in satisfied patients.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
T therapy in males with central hypogonadism reduces fat mass and increases fat-free mass.
“T therapy in males with central hypogonadism reduces fat mass and increases fat-free mass (132,135,140,148,149).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [148]
The Introduction reports improvements in body weight and waist circumference with testosterone replacement therapy, and the Results report patient-perceived improvement in muscle mass. Neither passage establishes reduced fat mass and increased fat-free mass specifically in men with central hypogonadism; the paper's mention of hypogonadotropic hypogonadism concerns secondary sexual characteristics instead. (LLM, conf=0.82)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Identification of late-onset hypogonadism in middle-aged and elderly men
Wu, F. C. W., Tajar, A., Beynon, J. M., Pye, S. R., Silman, A. J., Finn, J. D., O'Neill, T. W., Bartfai, G., Casanueva, F. F., Forti, G., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0911101 · Cited by 1,544 · see citing works
The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications
Kaufman, J. M., & Vermeulen, A. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0013 · Cited by 1,079 · see citing works
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2847 · Cited by 965 · see citing works
Prevalence of hypogonadism in males aged at least 45 years: the HIM study
MULLIGAN, T., FRICK, M. F., ZURAW, Q. C., STEMHAGEN, A., & MCWHIRTER, C. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.00992.x · Cited by 767 · see citing works
Wang, C., Cunningham, G., Dobs, A., Iranmanesh, A., Matsumoto, A. M., Snyder, P. J., Weber, T., Berman, N., Hull, L., & Swerdloff, R. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032006 · Cited by 656 · see citing works
Effects of Testosterone Replacement in Hypogonadal Men1
Snyder, P. J., Peachey, H., Berlin, J. A., Hannoush, P., Haddad, G., Dlewati, A., Santanna, J., Loh, L., Lenrow, D. A., Holmes, J. H., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6731 · Cited by 608 · see citing works
Araujo, A. B., O’Donnell, A. B., Brambilla, D. J., Simpson, W. B., Longcope, C., Matsumoto, A. M., & McKinlay, J. B. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031719 · Cited by 591 · see citing works
Kupelian, V., Page, S. T., Araujo, A. B., Travison, T. G., Bremner, W. J., & McKinlay, J. B. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1326 · Cited by 561 · see citing works
Association of Specific Symptoms and Metabolic Risks with Serum Testosterone in Older Men
Zitzmann, M., Faber, S., & Nieschlag, E. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0401 · Cited by 552 · see citing works
Hak, A. E., Witteman, J. C. M., de Jong, F. H., Geerlings, M. I., Albert Hofman, D., & Pols, H. A. P. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.8.3632 · Cited by 480 · see citing works
Effects of Testosterone Replacement in Hypogonadal Men
Snyder, P. J. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.8.2670 · Cited by 464 · see citing works
Testosterone replacement therapy improves mood in hypogonadal men--a clinical research center study
Wang, C., Alexander, G. M., Berman, N., Salehian, B., Davidson, T., McDonald, V., Steiner, B., Hull, L., Callegari, C. C., & Swerdloff, R. S. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.10.8855804 · Cited by 453 · see citing works
Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study
Corona, G., Rastrelli, G., Monami, M., Guay, A., Buvat, J., Sforza, A., Forti, G., Mannucci, E., & Maggi, M. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0447 · Cited by 435 · see citing works
The benefits and risks of testosterone replacement therapy: a review
Morley, J. E. (2009) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s3025 · Cited by 375 · see citing works
Type 2 diabetes mellitus and testosterone: a meta-analysis study: Type 2 diabetes and testosterone
Corona, G., Monami, M., Rastrelli, G., Aversa, A., Sforza, A., Lenzi, A., Forti, G., Mannucci, E., & Maggi, M. (2011) · International Journal of Andrology · doi:10.1111/j.1365-2605.2010.01117.x · Cited by 370 · see citing works
Heufelder, A. E., Saad, F., Bunck, M. C., & Gooren, L. (2009) · Journal of Andrology · doi:10.2164/jandrol.108.007005 · Cited by 349 · see citing works
Long-Term Pharmacokinetics of Transdermal Testosterone Gel in Hypogonadal Men 1
Swerdloff, R. S., Wang, C., Cunningham, G. R., Dobs, A. S., Iranmanesh, A., Matsumoto, A. M., Snyder, P. J., Weber, T. J., Longstreth, J. A., & Berman, N. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.12.7045 · Cited by 343 · see citing works
Trends in androgen prescribing in the United States, 2001 to 2011
Baillargeon, J., Urban, R. J., Ottenbacher, K. J., Pierson, K. S., & Goodwin, J. S. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.6895 · Cited by 336 · see citing works
Buvat, J., Maggi, M., Guay, A. T., & Torres, L. O. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02783.x · Cited by 281 · see citing works
Blood Testosterone Threshold for Androgen Deficiency Symptoms
Kelleher, S., Conway, A. J., & Handelsman, D. J. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0143 · Cited by 273 · see citing works
Long-Term Pharmacokinetics of Transdermal Testosterone Gel in Hypogonadal Men
Swerdloff, R. S. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.12.4500 · Cited by 262 · see citing works
Onset of effects of testosterone treatment and time span until maximum effects are achieved
Saad, F., Aversa, A., Isidori, A. M., Zafalon, L., Zitzmann, M., & Gooren, L. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0221 · Cited by 232 · see citing works
Pathogenesis of the decreased androgen levels in obese men.
Giagulli, V. A., Kaufman, J. M., & Vermeulen, A. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.4.7962311 · Cited by 215 · see citing works
Traish, A. M., Miner, M. M., Morgentaler, A., & Zitzmann, M. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.12.027 · Cited by 206 · see citing works
Hackett, G., Cole, N., Bhartia, M., Kennedy, D., Raju, J., & Wilkinson, P. (2013) · The Journal of Sexual Medicine · doi:10.1111/jsm.12146 · Cited by 182 · see citing works
McNicholas, T. A., Dean, J. D., Mulder, H., Carnegie, C., & Jones, N. A. (2003) · BJU International · doi:10.1046/j.1464-410x.2003.04016.x · Cited by 178 · see citing works
Saad, F., Haider, A., Doros, G. D., & Traish, A. M. (2013) · Obesity · doi:10.1002/oby.20407 · Cited by 165 · see citing works
A BRIEF HISTORY OF TESTOSTERONE
FREEMAN, E. R., Bloom, D. A., & McGuire, E. J. (2001) · The Journal of Urology · doi:10.1097/00005392-200102000-00004 · Cited by 156 · see citing works
Testosterone, cardiovascular disease and the metabolic syndrome
Corona, G., Rastrelli, G., Vignozzi, L., Mannucci, E., & Maggi, M. (2011) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.07.002 · Cited by 152 · see citing works
von Eckardstein, S., & Nieschlag, E. (2002) · Journal of Andrology · doi:10.1002/j.1939-4640.2002.tb02249.x · Cited by 144 · see citing works
Hormone Replacement Therapy and Physical Function in Healthy Older Men. Time to Talk Hormones?
Giannoulis, M. G., Martin, F. C., Nair, K. S., Umpleby, A. M., & Sonksen, P. (2012) · Endocrine Reviews · doi:10.1210/er.2012-1002 · Cited by 132 · see citing works
Hypogonadism and metabolic syndrome.
(2011) · PubMed · doi:10.3275/7806 · Cited by 125 · see citing works
Shores, M. M., Kivlahan, D. R., Sadak, T. I., Li, E. J., & Matsumoto, A. M. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04478 · Cited by 122 · see citing works
Improvement of Sexual Function in Men with Late-Onset Hypogonadism Treated with Testosterone Only
Yassin, A. A., & Saad, F. (2007) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2007.00442.x · Cited by 101 · see citing works
de Ronde, W. (2008) · Human Reproduction · doi:10.1093/humrep/den372 · Cited by 93 · see citing works
Emerging medication for the treatment of male hypogonadism
Corona, G., Rastrelli, G., Vignozzi, L., & Maggi, M. (2012) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2012.683411 · Cited by 93 · see citing works
Testosterone therapy in hypogonadal men results in sustained and clinically meaningful weight loss
Yassin, A. A., & Doros, G. D. (2013) · Clinical Obesity · doi:10.1111/cob.12022 · Cited by 92 · see citing works
Welcoming low testosterone as a cardiovascular risk factor
Maggio, M. G., & Basaria, S. S. (2009) · International Journal of Impotence Research · doi:10.1038/ijir.2009.25 · Cited by 84 · see citing works
Haider, A., Gooren, L. J. G., Padungtod, P., & Saad, F. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1202774 · Cited by 83 · see citing works
Rhoden, E. L., & Morgentaler, A. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01544.x · Cited by 83 · see citing works
Agledahl, I., Skjærpe, P. A., Hansen, J., & Svartberg, J. B. (2007) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.01.014 · Cited by 77 · see citing works
Schoenfeld, M. J., Shortridge, E. F., Cui, Z. L., & Muram, D. (2013) · The Journal of Sexual Medicine · doi:10.1111/jsm.12114 · Cited by 73 · see citing works
Marbury, T. C., Hamill, E., Bachand, R. T., et al. (2003) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.345 · Cited by 71 · see citing works
The evidence for seasonal variations of testosterone in men
Smith, R. P., Coward, R. M., Kovac, J. R., & Lipshultz, L. I. (2013) · Maturitas · doi:10.1016/j.maturitas.2012.12.003 · Cited by 66 · see citing works
Self-citationTestosterone treatment in the aging male: myth or reality?
Nigro, N., & Christ‐Crain, M. (2012) · Swiss Medical Weekly · doi:10.4414/smw.2012.13539 · Cited by 59 · see citing works
Hormone kinetics after intramuscular testosterone cypionate
Nankin, H. R. (1987) · Fertility and Sterility · doi:10.1016/s0015-0282(16)59237-1 · Cited by 54 · see citing works
McCullough, A., Khera, M., Goldstein, I., Hellstrom, W. J. G., Morgentaler, A., & Levine, L. A. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2011.02570.x · Cited by 52 · see citing works
Chiang, H., Cho, S.-L., Lin, Y., & Hwang, T. I. S. (2009) · Urology · doi:10.1016/j.urology.2008.10.019 · Cited by 52 · see citing works
The 20-Year Public Health Impact and Direct Cost of Testosterone Deficiency in U.S. Men
Moskovic, D. J., de Araújo, A. B., Lipshultz, L. I., & Khera, M. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02944.x · Cited by 47 · see citing works
Self-citationTestosterone and men's quality of life
Moncada, I. (2006) · The Aging Male · doi:10.1080/13685530601003180 · Cited by 45 · see citing works
Pharmacokinetic Evaluation and Dosing of Subcutaneous Testosterone Pellets
Pastuszak, A. W., Mittakanti, H. R., Liu, J. S., Gomez, L., Lipshultz, L. I., & Khera, M. (2012) · Journal of Andrology · doi:10.2164/jandrol.111.016295 · Cited by 44 · see citing works
Self-citationGiagulli, V. A., Triggiani, V., Carbone, M. D., Corona, G., Tafaro, E., Licchelli, B., & Guastamacchia, E. (2011) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2011.02497.x · Cited by 32 · see citing works
Grober, E. D., Khera, M., Soni, S. D., Espinoza, M. G., & Lipshultz, L. I. (2007) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901618 · Cited by 30 · see citing works
Self-citationSmith, R. P., Khanna, A., Coward, R. M., Rajanahally, S., Kovac, J. R., Gonzales, M., & Lipshultz, L. I. (2013) · The Journal of Sexual Medicine · doi:10.1111/jsm.12226 · Cited by 28 · see citing works
Self-citationThe latest options and future agents for treating male hypogonadism
Edelstein, D. L., Sivanandy, M. S., Shahani, S., & Basaria, S. S. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.17.2991 · Cited by 23 · see citing works
Moisey, R. S., Swinburne, J., & Orme, S. M. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03251.x · Cited by 18 · see citing works
Testosterone and cardiovascular risk in patients with erectile dysfunction.
Corona, G., Rastrelli, G., Balercia, G., Sforza, A., Forti, G., & Maggi, M. (2012) · PubMed · doi:10.3275/8063 · Cited by 16 · see citing works
McGriff-Lee, N. J., Csákó, G., Kabbani, M., Diep, L., Chrousos, G. P., & Pucino, F. (2001) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.21.17.1425.34428 · Cited by 15 · see citing works
Testosterone and cardiovascular risk in patients with erectile dysfunction
Corona, G., Rastrelli, G., Balercia, G., et al. (2012) · Florence Research (University of Florence) · Cited by 6 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
Fleseriu, M., Hashim, I. A., Karavitaki, N., Melmed, S., Murad, M. H., Salvatori, R., & Samuels, M. H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2118 · Cited by 945 · see citing works
Khera, M., Adaikan, G., Buvat, J., Carrier, S., El-Meliegy, A., Hatzimouratidis, K., McCullough, A., Morgentaler, A., Torres, L. O., & Salonia, A. (2016) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2016.10.009 · Cited by 177 · see citing works
Erythrocytosis Following Testosterone Therapy
Ohlander, S. J., Varghese, B., & Pastuszak, A. W. (2018) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2017.04.001 · Cited by 168 · see citing works
- Authors
- Kovac, J. R., Rajanahally, S., Smith, R. P., Coward, R. M., Lamb, D. J., & Lipshultz, L. I.
- Affiliations
- Baylor College of Medicine (US)
- Corresponding author
- Kovac, Jason R.
- Venue
- The Journal of Sexual Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-02-01
- Volume
- 11
- Issue
- 2
- Pages
- 553-562
- ISSN
- 1743-6095 (ISSN-L)
- 1743-6109
- PMC
- PMC3946859
- OpenAlex
- W1557237798
- Cited by
- 42
- References
- 59
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 1 · 2023: 3 · 2022: 4 · 2021: 3 · 2020: 3 · 2019: 2 · 2018: 1 · 2017: 5 · 2016: 7 · 2015: 5 · 2014: 3
- FWCI
- 3.94
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- The Journal of Sexual Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (K12, HD073917-01)
- Eunice Kennedy Shriver NICHD (P01HD36289, 1R01DK078121)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- testosterone replacement therapy, male hypogonadism, patient satisfaction, treatment preferences, injectable testosterone, testosterone gel, treatment costs, convenience, mood improvement, concentration
- MeSH terms
- Drug Implants, Gels, Humans, Hypogonadism, Male, Middle Aged, Prospective Studies, Testosterone, Patient Satisfaction, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review